A semi-invariant Vα 10+ T cell antigen receptor defines a population of natural killer T cells with distinct glycolipid antigen-recognition properties

Nature Immunology

Volumn 12, Issue 7, 2011, Pages 616-623

  Uldrich, Adam P ^a   Patel, Onisha ^b   Cameron, Garth ^a   Pellicci, Daniel G ^a   Day, E Bridie ^a   Sullivan, Lucy C ^a   Kyparissoudis, Konstantinos ^a   Kjer Nielsen, Lars ^a   Vivian, Julian P ^b   Cao, Benjamin ^c   Brooks, Andrew G ^a   Williams, Spencer J ^c   Illarionov, Petr ^d   Besra, Gurdyal S ^d   Turner, Stephen J ^a   Porcelli, Steven A ^e   McCluskey, James ^a   Smyth, Mark J ^a,f   Rossjohn, Jamie ^b   Godfrey, Dale I ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^f PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; ALPHA GLUCURONIC ACID; CD1D ANTIGEN; GLUCURONIC ACID; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ALPHA CHAIN; AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; LYMPHOCYTE SUBPOPULATION; MOLECULAR DOCKING; MOLECULAR RECOGNITION; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STRUCTURE; RAT;

ADJUVANTS, IMMUNOLOGIC; AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, BACTERIAL; ANTIGENS, CD1D; CELL LINE; GALACTOSYLCERAMIDES; GLUCURONIC ACIDS; HUMANS; MICE; MICE, MUTANT STRAINS; MOLECULAR SEQUENCE DATA; NATURAL KILLER T-CELLS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA;

EID: 79959375627     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.2051     Document Type: Article

References (51)

1. Godfrey, D.I., MacDonald, H.R., Kronenberg, M., Smyth, M.J. & Van Kaer, L. NKT cells: what's in a name? Nat. Rev. Immunol. 4, 231-237 (2004). (Pubitemid 38339089)
2. Cardell, S. et al. CD1-restricted CD4+ T cells in major histocompatibility complex class II-deficient mice. J. Exp. Med. 182, 993-1004 (1995).
3. Park, S.H. et al. The mouse CD1d-restricted repertoire is dominated by a few autoreactive T cell receptor families. J. Exp. Med. 193, 893-904 (2001).
4. Blomqvist, M. et al. Multiple tissue-specific isoforms of sulfatide activate CD1d-restricted type II NKT cells. Eur. J. Immunol. 39, 1726-1735 (2009).
5. Cui, J.Q. et al. Requirement for V14 NKT cells in Il-12-mediated rejection of tumors. Science 278, 1623-1626 (1997).
6. Renukaradhya, G.J. et al. Type I NKT cells protect (and type II NKT cells suppress) the host's innate antitumor immune response to a B cell lymphoma. Blood 111, 5637-5645 (2008).
7. Kim, J.H., Choi, E.Y. & Chung, D.H. Donor bone marrow type II (non-V14J18 CD1d-restricted) NKT cells suppress graft-versus-host disease by producing IFN-γ and IL-4. J. Immunol. 179, 6579-6587 (2007).
8. Terabe, M. et al. A nonclassical non- V14J18 CD1d-restricted (type II) NKT cell is sufficient for down-regulation of tumor immunosurveillance. J. Exp. Med. 202, 1627-1633 (2005). (Pubitemid 41815868)
9. Berzins, S.P., Smyth, M.J. & Godfrey, D.I. Working with NKT cells-pitfalls and practicalities. Curr. Opin. Immunol. 17, 448-454 (2005).
10. Gadola, S.D. et al. Structure and binding kinetics of three different human CD1d-α-galactosylceramide-specific T cell receptors. J. Exp. Med. 203, 699-710 (2006).
11. Gadola, S.D., Dulphy, N., Salio, M. & Cerundolo, V. V alpha 24-J alpha Q-independent, CD1d-restricted recognition of alpha-galactosylceramide by human CD4+ and CD8αβ+ T lymphocytes. J. Immunol. 168, 5514-5520 (2002).
12. Brigl, M. et al. Conserved and heterogeneous lipid antigen specificities of CD1d-restricted NKT cell receptors. J. Immunol. 176, 3625-3634 (2006). (Pubitemid 43364010)
13. Godfrey, D.I. et al. Antigen recognition by CD1d-restricted NKT T cell receptors. Semin. Immunol. 22, 61-67 (2010).
14. Pellicci, D.G. et al. Differential recognition of CD1d-alpha-galactosyl ceramide by the V8.2 and V7 semi-invariant NKT T cell receptors. Immunity 31, 47-59 (2009).
15. Borg, N.A. et al. CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor. Nature 448, 44-49 (2007). (Pubitemid 47037002)
16. Li, Y. et al. The V14 invariant natural killer T cell TCR forces microbial glycolipids and CD1d into a conserved binding mode. J. Exp. Med. 207, 2383-2393 (2010).
17. Wun, K.S. et al. A molecular basis for the exquisite CD1d-restricted Ag-specificity and functional responses of NKT cells. Immunity 34, 327-339 (2011).
18. Mallevaey, T. et al. The molecular basis of NKT cell autoreactivity and recognition of self-CD1d. Immunity 34, 315-326 (2011).
19. Wun, K.S. et al. A minimal binding footprint on CD1d-glycolipid is a basis for selection of the unique human NKT TCR. J. Exp. Med. 205, 939-949 (2008). (Pubitemid 351549889)
20. Scott-Browne, J.P. et al. Germline-encoded recognition of diverse glycolipids by natural killer T cells. Nat. Immunol. 8, 1105-1113 (2007). (Pubitemid 47423758)
21. Mallevaey, T. et al. T cell receptor CDR2β and CDR3β loops collaborate functionally to shape the iNKT cell repertoire. Immunity 31, 60-71 (2009).
22. Florence, W.C. et al. Adaptability of the semi-invariant natural killer T-cell receptor towards structurally diverse CD1d-restricted ligands. EMBO J. 28, 3579-3590 (2009).
23. Stenstrom, M., Skold, M., Andersson, A. & Cardell, S.L. Natural killer T-cell populations in C57BL/6 and NK1.1 congenic BALB.NK mice-a novel thymic subset defined in BALB.NK mice. Immunology 114, 336-345 (2005). (Pubitemid 40314806)
24. Yu, K.O. et al. Modulation of CD1d-restricted NKT cell responses by using N-acyl variants of α-galactosylceramides. Proc. Natl. Acad. Sci. USA 102, 3383-3388 (2005). (Pubitemid 40328054)
25. Jervis, P.J. et al. Synthesis and biological activity of α-glucosyl C24:0 and C20:2 ceramides. Bioorg. Med. Chem. Lett. 20, 3475-3478 (2010).
26. Wolucka, B.A., McNeil, M.R., Kalbe, L., Cocito, C. & Brennan, P.J. Isolation and characterization of a novel glucuronosyl diacylglycerol from Mycobacterium smegmatis. Biochim. Biophys. Acta 1170, 131-136 (1993). (Pubitemid 23308224)
27. Kawano, T. et al. Cd1d-restricted and TCR-mediated activation of V14 NKT cells by glycosylceramides. Science 278, 1626-1629 (1997). (Pubitemid 27516282)
28. Kinjo, Y. et al. Recognition of bacterial glycosphingolipids by natural killer T cells. Nature 434, 520-525 (2005). (Pubitemid 40477061)
29. Mattner, J. et al. Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 434, 525-529 (2005). (Pubitemid 40477062)
30. Sriram, V., Du, W., Gervay-Hague, J. & Brutkiewicz, R.R. Cell wall glycosphingolipids of Sphingomonas paucimobilis are CD1d-specific ligands for NKT cells. Eur. J. Immunol. 35, 1692-1701 (2005). (Pubitemid 40862317)
31. Zhou, D. et al. Lysosomal glycosphingolipid recognition by NKT cells. Science 306, 1786-1789 (2004). (Pubitemid 39601398)
32. Dias, B.R. et al. Identification of iGb3 and iGb4 in melanoma B16F10-Nex2 cells and the iNKT cell-mediated antitumor effect of dendritic cells primed with iGb3. Mol. Cancer 8, 116-129 (2009).
33. Kjer-Nielsen, L. et al. A structural basis for selection and cross-species reactivity of the semi-invariant NKT cell receptor in CD1d/glycolipid recognition. J. Exp. Med. 203, 661-673 (2006).
34. Feng, D., Bond, C.J., Ely, L.K., Maynard, J. & Garcia, K.C. Structural evidence for a germline-encoded T cell receptor-major histocompatibility complex interaction 'codon'. Nat. Immunol. 8, 975-983 (2007). (Pubitemid 47300012)
35. Dai, S. et al. Crossreactive T Cells spotlight the germline rules for αβ T cell-receptor interactions with MHC molecules. Immunity 28, 324-334 (2008).
36. Godfrey, D.I., Rossjohn, J. & McCluskey, J. The fidelity, occasional promiscuity, and versatility of T cell receptor recognition. Immunity 28, 304-314 (2008). (Pubitemid 351343861)
37. Smiley, S.T., Kaplan, M.H., Grusby, M.J. & Immunoglobulin, E. Production in the absence of interleukin-4-secreting Cd1-dependent cells. Science 275, 977-979 (1997). (Pubitemid 27087713)
38. Sonoda, K.H., Exley, M., Snapper, S., Balk, S.P. & Stein-Streilein, J. CD1-reactive natural killer T cells are required for development of systemic tolerance through an immune-privileged site. J. Exp. Med. 190, 1215-1226 (1999).
39. Crowe, N.Y. et al. Differential antitumor immunity mediated by NKT cell subsets in vivo. J. Exp. Med. 202, 1279-1288 (2005). (Pubitemid 41586958)
40. Long, X. et al. Synthesis and evaluation of stimulatory properties of Sphingomonadaceae glycolipids. Nat. Chem. Biol. 3, 559-564 (2007). (Pubitemid 47294396)
41. Casanova, J.L., Romero, P., Widmann, C., Kourilsky, P. & Maryanski, J.L. T cell receptor genes in a series of class I major histocompatibility complex-restricted cytotoxic T lymphocyte clones specific for a Plasmodium berghei nonapeptide: implications for T cell allelic exclusion and antigen-specific repertoire. J. Exp. Med. 174, 1371-1383 (1991).
42. Day, E.B. et al. The context of epitope presentation can influence functional quality of recalled influenza A virus-specific memory CD8+ T cells. J. Immunol. 179, 2187-2194 (2007).
43. Kedzierska, K., Turner, S.J. & Doherty, P.C. Conserved T cell receptor usage in primary and recall responses to an immunodominant influenza virus nucleoprotein epitope. Proc. Natl. Acad. Sci. USA 101, 4942-4947 (2004). (Pubitemid 38469182)
44. Lefranc, M.P. et al. IMGT, the International ImMunoGeneTics database. Nucleic Acids Res. 26, 297-303 (1998).
45. Garboczi, D.N. et al. Assembly, specific binding, and crystallization of a human TCR-αβ with an antigenic Tax peptide from human T lymphotropic virus type 1 and the class I MHC molecule HLA-A2. J. Immunol. 157, 5403-5410 (1996). (Pubitemid 126448959)
46. Holst, J. et al. Generation of T-cell receptor retrogenic mice. Nat. Protoc. 1, 406-417 (2006).
47. Leslie, A.G.W. Joint CCP4 + ESF-EAMCB Newsletter on Protein Crystallography. Recent changes to the MOSFLM package for processing film and image plate data 26 (1992).
48. CCP4 (Collaborative Computational Project, 4). The CCP4 suite: Programs for protein crystallography. Acta Crystallogr. D Biol. Crystallogr. 50, 760-763 (1994).
49. Otwinoski, Z. & Minor, W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276, 307-326 (1997). (Pubitemid 27085611)
50. Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60, 2126-2132 (2004). (Pubitemid 41742764)
51. Zajonc, D.M. et al. Structure and function of a potent agonist for the semi-invariant natural killer T cell receptor. Nat. Immunol. 6, 810-818 (2005). (Pubitemid 43090467)